Indication Lymphome agressif à cellules B récidivant ou ... - CHUV
Home | SAKK
CAREFOR, The Clinical Academic Cancer Research Forum
Swiss Group for Clinical Cancer Research (SAKK) – Breast Cancer Project Group | Breast Cancer Online | Cambridge Core
Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer
Tweets with replies by SAKK (@SAKK_ch) / Twitter
Organization
Methods in Clinical Cancer Research (MCCR) 2021 | ESMO
Long‐term outcome of dasatinib first‐line treatment in gastrointestinal stromal tumor: A multicenter, 2‐stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07) - Montemurro - 2018 - Cancer - Wiley Online Library
Talidox | InnoMedica
ZOOM SAKK 30/10 HOVON 103 Indication ... - Cancer Lausanne
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK - ScienceDirect
Francesco Bertoni has been elected as President of the Lymphoma Project Group of Swiss Group for Clinical Cancer Research
SAKK Swiss Group for Clinical Cancer Research Overview | SignalHire Company Profile
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non–Small‐cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial | Semantic Scholar
PDF) Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. | Semantic Scholar
Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). - Abstract - Europe PMC
GitHub - IDSC-io/sakk: Swiss Group for Clinical Cancer Research SAKK
Swiss Group for Clinical Cancer Research (SAKK) – Life Science Zurich Business Network
Home | SAKK
International Journal of Colorectal Disease | Volume 32, issue 1
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. | Semantic Scholar
9th Masterclass in Clinical Oncology for Residents of Oncologic Specialties: Workshops and Case Presentations – University of Ioannina
Home | SAKK
